An accurate and early diagnosis of bladder cancer (BC) is essential to offer patients the most appropriate treatment and the highest cure rate. For this reason, patients need to be best stratified by class and risk factors. We aimed to develop a score able to better predict cancer outcomes, using serum variables of inflammation.
Systemic combining inflammatory score (SCIS): A new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer / Ferro M.; Di Mauro M.; Cimino S.; Morgia G.; Lucarelli G.; Abu Farhan A.R.; Vartolomei M.D.; Porreca A.; Cantiello F.; Damiano R.; Busetto G.M.; Del Giudice F.; Hurle R.; Perdona S.; Borghesi M.; Bove P.; Autorino R.; Crisan N.; Marchioni M.; Schips L.; Soria F.; Mari A.; Minervini A.; Veccia A.; Battaglia M.; Terracciano D.; Musi G.; Cordima G.; Muto M.; Mirone V.; de Cobelli O.; Russo G.I.. - In: TRANSLATIONAL ANDROLOGY AND UROLOGY. - ISSN 2223-4691. - ELETTRONICO. - 10:(2021), pp. 626-635. [10.21037/TAU-20-1272]
Systemic combining inflammatory score (SCIS): A new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
Ferro M.;Cimino S.;Morgia G.;Lucarelli G.;Damiano R.;Mari A.;Minervini A.;Terracciano D.;
2021
Abstract
An accurate and early diagnosis of bladder cancer (BC) is essential to offer patients the most appropriate treatment and the highest cure rate. For this reason, patients need to be best stratified by class and risk factors. We aimed to develop a score able to better predict cancer outcomes, using serum variables of inflammation.
| File | Dimensione | Formato | |
|---|---|---|---|
|
10.21037-tau-20-1272.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
550.65 kB
Formato
Adobe PDF
|
550.65 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
